- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
South San Francisco Today
By the People, for the People
Rigel Pharmaceuticals Grants Inducement RSUs to New Hires
Biotech firm approves stock awards for six non-executive employees under Nasdaq rules.
Apr. 7, 2026 at 12:05pm
Got story updates? Submit your updates here. ›
Rigel Pharmaceuticals' strategic use of stock-based compensation aims to attract and retain top talent in the competitive biotech industry.South San Francisco TodayRigel Pharmaceuticals, Inc., a biotechnology company based in South San Francisco, California, has granted 8,925 restricted stock units (RSUs) to six new non-executive employees as inducement awards. The stock grants were approved by Rigel's Compensation Committee and are in accordance with Nasdaq Listing Rule 5635(c)(4), which allows for such inducement awards to new hires.
Why it matters
Rigel's inducement grants to new hires demonstrate the company's efforts to attract and retain top talent in the competitive biotech industry. These types of stock-based compensation packages are common practice for publicly traded firms looking to incentivize new employees and align their interests with shareholders.
The details
The RSUs granted to the six new non-executive hires at Rigel will vest over a four-year period, with 25% of the total award vesting each year. Inducement grants like these are designed to encourage long-term commitment from new employees as they build their careers at the company.
- Rigel announced the inducement grants on April 7, 2026.
The players
Rigel Pharmaceuticals, Inc.
A biotechnology company dedicated to discovering, developing and providing novel therapies that improve the lives of patients with hematologic disorders and cancer. Rigel is based in South San Francisco, California and is publicly traded on the Nasdaq exchange under the ticker symbol RIGL.
The takeaway
Rigel's use of inducement grants to attract new talent reflects the competitive nature of the biotech industry, where companies must offer attractive compensation packages to recruit and retain skilled employees. These types of stock-based awards aim to incentivize long-term commitment and align the interests of new hires with the company's shareholders.
